Dr Reddy's Laboratories Limited has entered into an exclusive distribution agreement Integra LifeSciences Holdings Corporation, the US-based medical technology company, to market and distribute Integra’s DuraGen Plus and Suturable DuraGen Dural Regeneration Matrices for use in patients in India.
“We are delighted to partner with Integra LifeSciences. With the launch of DuraGen, we look forward to building our presence in the segment of regenerative technologies and making a difference to the lives of patients undergoing neurosurgery,” opined M V Ramana, executive vice president and head of emerging markets & India business, Dr Reddy’s Laboratories.
Glenn Coleman, chief financial officer and corporate vice